Topic: Pandemrix

A new study suggests that Alzheimer's disease may be transmissible via brain tissue, which the hosts interpret as a potential setup for a new vaccine. Meanwhile, in Finland, the government is providing compensation to victims of the Pandemrix swine flu vaccine who developed narcolepsy. The hosts contrast this with US laws that protect pharmaceutical companies from similar lawsuits.

Health authorities in Ireland and Finland have moved to withdraw stocks of the Pandemrix swine flu vaccine. The decision follows clinical evidence linking the vaccine to the development of narcolepsy, a disabling sleep disorder, in children and adolescents.

A national panel in Finland has confirmed that the Pandemrix swine flu vaccine increased the risk of narcolepsy in children by nearly tenfold. Despite 52 Finnish children developing the lifelong condition, the hosts note that the story has received very little mainstream media coverage in the U.S. They discuss an article suggesting that manufactured epidemics are used for "demand destruction" and population management.

An analysis of a GlaxoSmithKline (GSK) investor PowerPoint reveals the company's focus on "adjuvanted" vaccines to increase production capacity. The hosts explain that adjuvants allow manufacturers to use less active antigen per dose, thereby increasing profit margins. They also touch on Monsanto's patents on genetically engineered pigs in relation to the "swine" flu meme.